Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Emcure Pharma divests mRNA business for Rs 139.5 crore to Immunoscript Life Science
Emcure Pharmaceuticals said that its subsidiary at Gennova Biopharmaceuticals has executed a business transfer agreement for transfer of its mRNA business as a going concern on a slump sale basis to Immunoscript Life Science.
Gennova Biopharmaceuticals to transfer its mRNA business to Immunoscript Life Science
Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, has executed a Business Transfer Agreement for transfer of its mRNA business as a going concern on a slump sale basis for a cash consideration of Rs 139.5 crore to Immunoscript Life Science on 10 July2026.
GSP Crop Science IPO opens today; should you apply? Here's what brokerages say
Ahead of the issue opening, agrochemical company GSP Crop Science raised ₹120 crore from two anchor investors. Mauritius-based Craft Emerging Market Fund PCC was the largest investor in the anchor book, purchasing nearly 25 lakh shares through two investment vehicles - Citadel Market Fund and Elite Capital Fund - for ₹80 crore. Shine Star Build Cap was the other anchor investor, acquiring 12.5 lakh shares worth ₹40 crore.
CCL Products, Sai Life Sciences on Mayuresh Joshi’s watchlist for earnings strength
Mayuresh Joshi, Director of Research at Marketsmith India, is watching earnings-resilient sectors such as consumer discretionary, banking, and pharmaceuticals as market remains volatile. Along with CCL Products and Sai Life Sciences, Strides Pharma Science and ICICI Bank are on his watchlist, while Vishal Mega Mart remains a domestic consumption play worth tracking.